NAT-TRABECTEDIN DIN 02523531
Health Canada record
| Active ingredient(s) | TRABECTEDIN 1 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01CX01 TRABECTEDIN |
| Original market date | |
| Current status date | 28-Oct-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Natco Pharma (Canada) Inc — licence 102058, currently licensed, last inspection rating C (2022-07-26).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRABECTEDIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02351528 | YONDELIS | VALEO PHARMA INC | Powder For Solution | TRABECTEDIN 1 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36266 | 2025-10-28 | Abbreviated New Drug Submission (ANDS) |
International API supply for TRABECTEDIN
8 active FDA Drug Master Files.
Request a quote for NAT-TRABECTEDIN